Zobrazeno 1 - 10 of 18 pro vyhledávání: '"Mary Ann McDonnell"'
1
A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings
Autor: Floyd R. Sallee, Mary Ann McDonnell, Andrea Marraffino, Norberto J. DeSousa, Bev Incledon, Sharon B. Wigal, Matthew Brams, John M. Turnbow, Ann C. Childress, Andrew J. Cutler
Publikováno v: Journal of Child and Adolescent Psychopharmacology
Objectives: HLD200, a once-daily, evening-dosed, delayed-release and extended-release methylphenidate (DR/ER-MPH), was designed to provide therapeutic effect beginning upon awakening and lasting into the evening. This pivotal, randomized, double-blin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1957af7b71e132269a47e8506436eec0
https://doi.org/10.1089/cap.2019.0070
Zobrazit plný text záznamu
3
Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised
Autor: Norberto J. DeSousa, Ann C. Childress, F. Randy Sallee, Sharon B. Wigal, Scott H. Kollins, Mary Ann McDonnell, Stephen V. Faraone
Publikováno v: Journal of Attention Disorders. 22:1066-1073
Objective: Children with ADHD frequently manifest behavioral difficulties in the morning prior to school. We sought to assess the reliability and validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised (DPREMB-R) morning sc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27bd2dabb01299eb4e5583ea1b27fc17
https://doi.org/10.1177/1087054715619009
Zobrazit plný text záznamu
4
A Treatment Optimization Study of HLD200 in Children with Attention-Deficit/Hyperactivity Disorder
Autor: Marina Komolova, Floyd R. Sallee, Ann C. Childress, Scott H. Kollins, Norberto J. DeSousa, Mary Ann McDonnell, Sharon B. Wigal
Publikováno v: Section on Advances in Therapeutics and Technology Program.
Purpose: This 6-week open-label, treatment optimization phase for an 11-week Phase III Clinical Endpoint Evaluation Study (CEES), examined the safety and efficacy of HLD200, a delayed- and extended-release formulation of methylphenidate (MPH) designe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a3dd63ebfd470c386e5deb86e0c159b6
https://doi.org/10.1542/peds.141.1_meetingabstract.257
Zobrazit plný text záznamu
5
A Phase III Study of HLD200 in Children with Attention-Deficit/Hyperactivity Disorder: Safety Results
Autor: Norberto J. DeSousa, Scott H. Kollins, Marina Komolova, Mary Ann McDonnell, Ann C. Childress, Floyd R. Sallee, Sharon B. Wigal
Publikováno v: Section on Advances in Therapeutics and Technology Program.
Purpose: This exploratory study consisted of a 6-week open-label, treatment optimization phase followed by a 1-week randomized, double-blind, placebo-controlled, parallel-group test phase to assess HLD200, a delayed- and extended-release formulation
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::33d61307e4aba28b0f4c3a9c61ea8d57
https://doi.org/10.1542/peds.141.1_meetingabstract.253
Zobrazit plný text záznamu
10
Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review
Autor: Joseph Biederman, Eric Mick, Richard Falzone, Janet Wozniak, Thomas J. Spencer, Megan Aleardi, Mary Ann McDonnell
Publikováno v: Scopus-Elsevier
BackgroundPediatric bipolar diorder is a serious neuropsychiatric disorder asociated with high levels of morbidity and disabilty.ObjectiveThis is a systematic chart review of all outpatient youth with the diagnosis of bipolar disorder and bipolar spe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d35c0e76f2a48e9cffeb00520850cb5
https://pubmed.ncbi.nlm.nih.gov/15685125
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje